Skip to content

13F-HR filed by BRIDGER MANAGEMENT, LLC

BRIDGER MANAGEMENT, LLC filed this 13F-HR for the quarter ended 2023-12-31, filed 2024-02-14, with 28 holding rows worth $259,545,769.

Accession
0001166309-24-000002
Filed
2024-02-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2023

A holdings report, 28 entries on the cover page, a total value of $259,545,769 stated on the cover page (in dollars after the unit check, H1), rows summing to $259,545,769 with VALUE read as dollars as filed, 13F file number 028-10079. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
Uber Technologies90353T100COM445,357$27,420,630dollars as filed
GODADDY INC CL A380237107Stock236,244$25,079,663dollars as filed
CAESARS ENTERTAINMENT INC NE12769G100COM427,925$20,061,124dollars as filed
Vertex Pharmaceuticals Incorporated92532F100COM48,000$19,530,720dollars as filed
Morgan Stanley617446448COM181,914$16,963,481dollars as filed
Eli Lilly and Company532457108COM28,076$16,366,062dollars as filed
TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS881624209ADR1,500,000$15,660,000dollars as filed
BATH & BODY WORKS INC COM070830104Stock332,327$14,343,233dollars as filed
US FOODS HLDG CORP COM912008109Stock312,331$14,182,951dollars as filed
ENDEAVOR GROUP HLDGS INC29260Y109CL A COM436,860$10,366,688dollars as filed
CHARTER COMMUNICATIONS INC N16119P108COM26,513$10,305,073dollars as filed
Pfizer Inc.717081103COM350,500$10,090,895dollars as filed
DOCEBO INC COM25609L105Stock192,892$9,332,115dollars as filed
CROWN HLDGS INC COM228368106Stock99,000$9,116,910dollars as filed
XENON PHARMACEUTICALS INC COM98420N105Stock146,800$6,761,608dollars as filed
QUANTERIX CORP74766Q101COMMON STOCK154,900$4,234,966dollars as filed
SPRINGWORKS THERAPEUTICS INC85205L107COM101,126$3,691,099dollars as filed
ACADIA PHARMACEUTICALS INC004225108COM117,341$3,673,947dollars as filed
ALNYLAM PHARMACEUTICALS INC COM02043Q107Stock18,922$3,621,860dollars as filed
WILLIAMS ROWLAND ACQUISITION96951B102COM297,000$3,112,560dollars as filed
ATRICURE INC04963C209COM87,100$3,108,599dollars as filed
CATALYST PHARMACEUTICALS INC14888U101COM184,527$3,101,899dollars as filed
UNIQURE NVN90064101SHS362,349$2,453,103dollars as filed
Alphabet Inc. Reg. Shares A02079K305COM13,900$1,941,691dollars as filed
MELCO RESORTS & ENTERTAINMENT585464100ADR214,763$1,904,948dollars as filed
CYTOKINETICS INC23282W605COM NEW22,510$1,879,360dollars as filed
Microsoft Corp594918104COM3,275$1,231,531dollars as filed
SURROZEN INC86889P117*W EXP 08/01/203466,666$9,053dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001166309-24-000002this filing2024-02-14acceptance time not in the bulk data set
13F-HR/A 0001166309-24-000010 added2024-03-25acceptance time not in the bulk data set